Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：A20-Tg(hCD40)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S26A-TM03
CD40 gene humanized A20 cell line
Strain Name：CT26-Cd86em1(hCD86)Smoc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-S24A-TM42
CD86 gene humanized CT26 cell line
Strain Name：CT26-Tg(hNECTIN4)Smoc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-S24A-TM44
Nectin4 gene humanized CT26 cell line
Strain Name：CT26-Tg(OVA)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230033
OVA gene humanized CT26 cell line
Strain Name：CT26-Tg(hFAP)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230018
FAP gene humanized CT26 cell line
Strain Name：4T1-Tg(hPSMA)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S07-TM05
PSMA gene humanized 4T1 cell line
Strain Name：MC38-Cd86em1(hCD86)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S13-TM89
CD86 gene humanized MC38 cell line
Strain Name：EMT6-Tg(MSLN)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S22A-TM03
MSLN gene humanized EMT6 cell line
Strain Name：A20-Cd22em1(hCD22)Smoc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230006
CD22 gene humanized A20 B cell line
Strain Name：CT26-Tg(hMSLN)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230029
MSLN gene humanized CT26 cell line
Please fill in the order form and we will contact you within 2 working days.
